Xiaoxia Wang

ORCID: 0000-0003-1888-9154 · 19 papers in corpus
2026
·doi:10.6084/m9.figshare.34285986

Supplementary Material 1.

2026
·doi:10.6084/m9.figshare.34285992

Supplementary Material 2.

2026
·doi:10.6084/m9.figshare.34285998

Supplementary Material 3.

2026
·doi:10.6084/m9.figshare.34286004

Supplementary Material 4.

other 2026
Stem cell research & therapy ·doi:10.1186/s13287-026-05166-3

BACKGROUND: Endometrial organoids, with their three-dimensional structure and robust hormonal responsiveness, have emerged as valuable models for investigating uterine physiology and embryo implantation. However, conventional derivation fro…

review 2026
·doi:10.31083/ceog48240

Objective: Endometriosis in adolescents is challenging to diagnose in its early stages, yet it is widespread among adolescent girls with chronic pelvic pain, posing a significant risk to their physical and mental health, as well as subseque…

rct 2024
PeerJ ·doi:10.7717/peerj.17813

BACKGROUND: To train highly qualified medical talent in 5-year programs and improve students' analytical and problem-solving abilities, it is necessary to change the traditional teaching method. This study introduces the combined teaching m…

observational 2023
American journal of translational research

OBJECTIVE: To analyze the therapeutic effect of acupuncture combined with mifepristone on uterine fibroids and its influence on sex hormones and inflammatory factors. METHODS: Data of 102 patients with uterine fibroids admitted to Shanxi P…

observational 2019
Medicine ·doi:10.1097/md.0000000000017540

To analyze the clinicopathological characteristics of pelvic masses after hysterectomy for benign diseases, and to analyze the related factors of benign and malignant pelvic masses.This study retrospectively analyzed the patients undergone …

observational 2019
Journal of ovarian research ·doi:10.1186/s13048-019-0504-6

OBJECTIVES: To analyze the clinicopathological characteristics of subsequent pelvic masses after hysterectomy for benign diseases, and to compare the masses following hysterectomy with or without simultaneous bilateral salpingectomy. METHO…

lab-animal 2012
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

AIM: To investigate the effect of Gonadotropin-realeasing hormone agonist (GnRHa) on apoptosis and the release of vascular endothelial growth factor (VEGF) in the in vitro eutopic endometrial cell of adenomyosis. METHODS: Biopsy specimens …

observational 2011

Objective To study the expressions of vascular endothelial growth factor (VEGF) and microvessel density(MVD)in eutopic and ectopic endometria in patients with adenomyosis and their clinical significance in occurrence of menorrhalgia and men…

lab-animal 2009

Objective To investigate the effect of Triptorelin on the release of tumor necrosis factor-α(TNF-α) and vascular endothelial growth factor (VEGF) in the in-vitro eutopic endometrial cells of adenomyosis.Methods Biopsy specimens of eutopic e…

rct 2009
Gynecologic and obstetric investigation ·doi:10.1159/000258683

AIMS: To determine the effects of gonadotropin-releasing hormone agonist (GnRH-a) and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis. METHODS: This was a prospective observational study …

observational 2009

Objective To detect the expression of vascular endothelial growth factor (VEGF),endostatin (ENS) and microvessel density(MVD)in eutopic and ectopic endometrium in adenomyosis(AM) and their relationship with clinical significance.Methods Imm…

lab-animal 2008
·doi:10.3760/cma.j.issn.1674-1927.2008.05.008

Objective To investigate the effects of gonadotropin releasing hormone analogues (GnRHa) on apoptosis of cultured adenomyosis (AM) endometrial cells. Methods Eutopic endometrial cells from 32 women who received hysterectomy for AM (study gr…

observational 2007
·doi:10.3760/cma.j.issn.1674-1927.2007.04.002

Objective To examine the expression of cell apoptosis repressor factor, Bcl-2 protein, celluar nucleus related antigen, Ki-67 antigen, estrogen receptor (ER) and progesterone receptor ( PR ) in eutopic and ectopic endometrium of adenomyosis…

rct 2006

Objective To study the effects of an extended-interval dosing regimen of gonadotropin releasing hormone agonist(GnRH-a) in the treatment of adenomyosis. Methods 20 patients with adenomyosis who asked for medicine treatment were divided into…

observational 2006
·doi:10.3877/cma.j.issn.1673-5250.2006.06.104

Objective To observe the expression of E-cadherin and CD44 v6 in human adenomyosis.To explore the correlation between the expression of E-cadherin and CD44 v6 in the pathogenesis of adenomyosis. Methods The expression of E-cadherin a…